Cargando…
Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure
AIMS: Loop diuretics are first‐line medications for congestive heart failure (CHF); however, they are associated with serious adverse effects, including decreased renal function, and sympathetic nervous and renin–angiotensin system activation. We tested whether tolvaptan, a vasopressin V2‐receptor a...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071712/ https://www.ncbi.nlm.nih.gov/pubmed/27818782 http://dx.doi.org/10.1002/ehf2.12088 |